Ignite Creation Date:
2025-12-24 @ 1:10 PM
Ignite Modification Date:
2026-02-25 @ 8:15 PM
Study NCT ID:
NCT03793361
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2018-12-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Regorafenib as Maintenance Therapy
Sponsor:
Centre Oscar Lambret
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EREMISS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None